ConductScience.org, home

Paper37795443

The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality.

Bray C and 3 others. Front Oncol, 2023. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality. Papers, record 37795443. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37795443

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality.
PubMed
Journal
Front Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
2.92
iCite
Revised in PubMed
2023-10-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bray CChandler
2Balcells CCristina
3McNeish IAIain A
4Keun HCHector C

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References111

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111343899Spliceosomal UsnRNP biogenesis, structure and function.Curr Opin Cell Biol2001https://conductscience.org/library/papers/11343899PubMed
220164920The landscape of somatic copy-number alteration across human cancers.Nature2010https://conductscience.org/library/papers/20164920PubMed
332025013The evolutionary history of 2,658 cancers.Nature2020https://conductscience.org/library/papers/32025013PubMed
434780697Human Mat2A Uses an Ordered Kinetic Mechanism and Is Stabilized but Not Regulated by Mat2B.Biochemistry2021https://conductscience.org/library/papers/34780697PubMed
56781742Abnormal regulation of methylthioadenosine and polyamine metabolism in methylthioadenosine phosphorylase-deficient human leukemic cell lines.Cancer Res1980https://conductscience.org/library/papers/6781742PubMed
68616780Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-alpha1, interferon-beta1, and other 9p21 markers in human malignant cell lines.Cancer Genet Cytogenet1996https://conductscience.org/library/papers/8616780PubMed
722143770Structural insights into protein arginine symmetric dimethylation by PRMT5.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/22143770PubMed
831408619Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation.Cancer Cell2019https://conductscience.org/library/papers/31408619PubMed
935264604MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarization.Sci Rep2022https://conductscience.org/library/papers/35264604PubMed
1028238654PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination.Mol Cell2017https://conductscience.org/library/papers/28238654PubMed
1124969958MTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patients.Eur J Surg Oncol2014https://conductscience.org/library/papers/24969958PubMed
1222327218Arginine methylation controls growth regulation by E2F-1.EMBO J2012https://conductscience.org/library/papers/22327218PubMed
1322446626DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation.Nature2012https://conductscience.org/library/papers/22446626PubMed
1431611688PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia.Nat Struct Mol Biol2019https://conductscience.org/library/papers/31611688PubMed
1517709427Two distinct arginine methyltransferases are required for biogenesis of Sm-class ribonucleoproteins.J Cell Biol2007https://conductscience.org/library/papers/17709427PubMed
1623363077Fluorinated N,N-dialkylaminostilbenes repress colon cancer by targeting methionine S-adenosyltransferase 2A.ACS Chem Biol2013https://conductscience.org/library/papers/23363077PubMed
173093064Methylthioadenosine phosphorylase deficiency in human leukemias and solid tumors.Cancer Res1986https://conductscience.org/library/papers/3093064PubMed
1828977470The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer.Nucleic Acids Res2017https://conductscience.org/library/papers/28977470PubMed
1933450196MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage.Cancer Cell2021https://conductscience.org/library/papers/33450196PubMed
2021074527Histone arginine methylation.FEBS Lett2011https://conductscience.org/library/papers/21074527PubMed

See all 111 referencesDownload CSV of references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
42938892MTAP Loss and Pleural Mesothelioma (PM): Current Treatment Strategies and Emerging Therapeutic Approaches.Cancers (Basel)2026https://conductscience.org/library/papers/42938892PubMed
42723945Case Report: Targeting EGFR exon 20 insertion and MTAP loss in refractory metastatic upper tract urothelial carcinoma.Front Oncol2026https://conductscience.org/library/papers/42723945PubMed
42436136Specimen quality shapes the actionable genomic landscape in comprehensive cancer genomic profiling.NPJ Genom Med2026https://conductscience.org/library/papers/42436136PubMed
42421155Tumor-type specific methylation patterns of MTAP in human samples and cell lines.Clin Epigenetics2026https://conductscience.org/library/papers/42421155PubMed
42374173Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types.Mol Med2026https://conductscience.org/library/papers/42374173PubMed
42129334MTAP loss in gastrointestinal cancers is associated with CDKN2A deletion, poor prognosis in gastric carcinoma, and potential relevance for PRMT5-targeted therapy.Sci Rep2026https://conductscience.org/library/papers/42129334PubMed
42092301Genetic analysis of primary lung interdigitating dendritic cell sarcomas.J Pathol2026https://conductscience.org/library/papers/42092301PubMed
42021873Exploiting Synthetic Lethality of PRMT5 for Precision Treatment of MTAP-Deficient Glioblastoma.Int J Transl Med (Basel)2025https://conductscience.org/library/papers/42021873PubMed
41899498Real-World Prevalence and Structural Validation of the Canonical 9p21 MTAP-CDKN2A/B Deletion in Non-NSCLC Solid Tumors.Cancers (Basel)2026https://conductscience.org/library/papers/41899498PubMed
41891959MS4322 is a selective protein arginine methyltransferase 5 degrader with antitumor effects in cervical cancer cells.Oncol Rep2026https://conductscience.org/library/papers/41891959PubMed
41537447Synthetic lethality in cancer therapy: Mechanisms, models and clinical translation for overcoming therapeutic resistance.Clin Transl Med2026https://conductscience.org/library/papers/41537447PubMed
41487038Targeting of CDK1 and PRMT5 as a potential therapeutic combination for non-small cell lung cancer.Histol Histopathol2026https://conductscience.org/library/papers/41487038PubMed
41465382MTAP Deletion as a Therapeutic Vulnerability in Cancer: From Molecular Mechanism to Clinical Targeting.Int J Mol Sci2025https://conductscience.org/library/papers/41465382PubMed
41439984MTAP-Null Tumors: A Comprehensive Review on Synthetic Vulnerabilities and Therapeutic Strategies.Cells2025https://conductscience.org/library/papers/41439984PubMed
41246302Immune suppression in MTAP-deficient cancers via glutamate metabolism and CXCL10 downregulation.Front Immunol2025https://conductscience.org/library/papers/41246302PubMed
40664803MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladder.Sci Rep2025https://conductscience.org/library/papers/40664803PubMed
40553452MTA-Cooperative PRMT5 Inhibitors Are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models.Clin Cancer Res2025https://conductscience.org/library/papers/40553452PubMed
40240755Perspectives on cancer therapy-synthetic lethal precision medicine strategies, molecular mechanisms, therapeutic targets and current technical challenges.Cell Death Discov2025https://conductscience.org/library/papers/40240755PubMed
40227771Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal Adenocarcinomas.Cancers (Basel)2025https://conductscience.org/library/papers/40227771PubMed
40006625Understanding the Toxicity Profile of Approved ADCs.Pharmaceutics2025https://conductscience.org/library/papers/40006625PubMed

See all 28 cited byDownload CSV of cited by

Genes72

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AMD1262PubTator's text mininghttps://conductscience.org/library/genes/262NCBI Gene
APAF1317PubTator's text mininghttps://conductscience.org/library/genes/317NCBI Gene
AR367PubTator's text mininghttps://conductscience.org/library/genes/367NCBI Gene
ATF4468PubTator's text mininghttps://conductscience.org/library/genes/468NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
CCNE1898PubTator's text mininghttps://conductscience.org/library/genes/898NCBI Gene
CD74972PubTator's text mininghttps://conductscience.org/library/genes/972NCBI Gene
CDC6990PubTator's text mininghttps://conductscience.org/library/genes/990NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
CDKN1A1026PubTator's text mininghttps://conductscience.org/library/genes/1026NCBI Gene
CDKN1C1028PubTator's text mininghttps://conductscience.org/library/genes/1028NCBI Gene
CDKN2A1029PubTator's text mininghttps://conductscience.org/library/genes/1029NCBI Gene
CDKN2C1031PubTator's text mininghttps://conductscience.org/library/genes/1031NCBI Gene
CIITA4261PubTator's text mininghttps://conductscience.org/library/genes/4261NCBI Gene
CLNS1A1207PubTator's text mininghttps://conductscience.org/library/genes/1207NCBI Gene
COPRS55352PubTator's text mininghttps://conductscience.org/library/genes/55352NCBI Gene
CTTN2017PubTator's text mininghttps://conductscience.org/library/genes/2017NCBI Gene
DHFR1719PubTator's text mininghttps://conductscience.org/library/genes/1719NCBI Gene
E2F11869PubTator's text mininghttps://conductscience.org/library/genes/1869NCBI Gene

See all 72 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37795443

GET https://conductscience.org/api/papers/v1/37795443/references?page=2